Page last updated: 2024-11-02

pifithrin and Autosomal Dominant Juvenile Parkinson Disease

pifithrin has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, W1
Zhu, X1
Ladenheim, B1
Yu, QS1
Guo, Z1
Oyler, J1
Cutler, RG1
Cadet, JL1
Greig, NH1
Mattson, MP1
Liang, ZQ1
Li, YL1
Zhao, XL1
Han, R1
Wang, XX1
Wang, Y1
Chase, TN1
Bennett, MC1
Qin, ZH1

Other Studies

2 other studies available for pifithrin and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.
    Annals of neurology, 2002, Volume: 52, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; bcl-2-Associated X Protein; Behavi

2002
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
    Brain research, 2007, May-11, Volume: 1145

    Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Benzothiazoles; DNA Fragmentation; Dopamine; Mal

2007